CLINICAL_TRIALS
withdrawal
· 2017-02-08
Clinical Trial Update: Treatment With hOKT3gamma1(Ala-Ala) in T1DM [Phase 2]
Summary
A Phase 2 clinical trial evaluating hOKT3gamma1(Ala-Ala) for Type 1 diabetes mellitus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: TERMINATED